Most patients with Alzheimer's disease present with amnestic problems; however, a
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …

Alzheimer's disease (AD) dementia refers to a particular onset and course of cognitive and
functional decline associated with age together with a particular neuropathology. It was first …

Aducanumab has been approved by the US Food and Drug Administration for treatment of
Alzheimer's disease (AD). Clinicians require guidance on the appropriate use of this new …

Research on racial differences in Alzheimer disease (AD) dementia has increased in recent
years. Older African American individuals bear a disproportionate burden of AD and …

Hearing loss is highly prevalent and may significantly affect how we age. Although the
population is aging, relatively few adults receive treatment for hearing loss. Internists are a …

Objectives An increasing reliance on telemedicine for older adults with cognitive impairment
requires a better understanding of the barriers and facilitators for this unique patient …

Importance Racial and ethnic groups with higher rates of clinical Alzheimer disease (AD) are
underrepresented in studies of AD biomarkers, including amyloid positron emission …

Importance The US aging population is rapidly becoming more racially and ethnically
diverse. Early diagnosis of dementia is a health care priority. Objective To examine the …

The APOE gene alleles modify human aging and the response to the diet at many levels
with diverse pleotropic effects from gut to brain. To understand interactions of APOE isoforms …

Abstract Background and Objectives Racial disparities in health and socioeconomic
characteristics of older adults have implications for the experiences of their family and …